Bibliografía
[1] European Cancer Information System from International Agency for Research on Cancer (IARC). Estimates of cancer incidence and mortality in 2022. n.d. https://ecis.jrc.ec.europa.eu/explorer.php (accessed April 25, 2024).
[2] Henderson RH, French D, Maughan T, et al. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study. Lancet Gastroenterol Hepatol 2021;6:709–22. https://doi.org/10.1016/S2468-1253(21)00147-3.
[3] Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol 2021;22:1002–13. https://doi.org/10.1016/S1470-2045(21)00199-6.
[4] Cayuela L, Rodríguez-Domínguez S, Giráldez Á, et al. Regional differences in colorectal cancer mortality trends, Spain (1980-2018). Revista Espanola de Enfermedades Digestivas 2021;113:570–5. https://doi.org/10.17235/reed.2020.7183/2020.
[5] Albillos A, Carballo F, Crespo J, et al. Strategic analysis and recommendations of the Sociedad Española de Patología Digestiva (SEPD) regarding population-based screening programs for colorectal cancer in Spain. Revista Espanola de Enfermedades Digestivas 2024;116:319–29. https://doi.org/10.17235/reed.2024.10458/2024.
[6] Ladabaum U, Dominitz JA, Kahi C, et al. Strategies for Colorectal Cancer Screening. Gastroenterology 2020;158:418–32. https://doi.org/10.1053/j.gastro.2019.06.043.
[7] Senore C, Lansdorp-Vogelaar I, de Jonge L, et al. Rationale for organized Colorectal cancer screening programs. Best Pract Res Clin Gastroenterol 2023;66:101850. https://doi.org/10.1016/j.bpg.2023.101850.
[8] Levin TR, Corley DA, Jensen CD, et al. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology 2018;155:1383-1391.e5. https://doi.org/10.1053/j.gastro.2018.07.017.
[9] Council of the European Union (CEU). Council recommendation of 2 December 2003 on cancer screening. Official Journal of the European Union 2003. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003:327:0034:0038:EN:PDF (accessed March 15, 2024).
[10] Albers B, Auer R, Caci L, et al. Implementing organized colorectal cancer screening programs in Europe-protocol for a systematic review of determinants and strategies. Syst Rev 2023;12:26. https://doi.org/10.1186/s13643-023-02193-6.
[11] Ebell MH, Thai TN, Royalty KJ. Cancer screening recommendations: an international comparison of high income countries. Public Health Rev 2018;39:7. https://doi.org/10.1186/s40985-018-0080-0.
[12] World Health Organization - Regional Office for Europe. A short guide to cancer screening - Increase effectiveness, maximize benefits and minimize harm. 2022. https://iris.who.int/bitstream/handle/10665/351396/9789289057561-eng.pdf?sequence=1&isAllowed=y (accessed April 25, 2024).
[13] Ministerio de Sanidad. Estrategia en Cáncer del Sistema Nacional de Salud (actualización aprobada por el Consejo Interterritorial del Sistema Nacional de Salud, el 24 de febrero de 2021). Ministerio de Sanidad y Política Social 2021. https://www.sanidad.gob.es/areas/calidadAsistencial/estrategias/cancer/docs/ESTRATEGIA_EN_CANCER_DEL_SNS.pdf (accessed March 10, 2024).
[14] Albillos A, Carballo F, Crespo J. Situación actual del cribado poblacional de cáncer colorrectal en España. Madrid: Sociedad Española de Patología Digestiva, 2024. ISBN: 978-84-09-61326-7.
[15] Ola I, Cardoso R, Hoffmeister M, et al. Utilization of colorectal cancer screening tests across European countries: a cross-sectional analysis of the European health interview survey 2018-2020. The Lancet Regional Health Europe 2024;41:100920. https://doi.org/10.1016/j.lanepe.2024.100920.
[16] Dressler J, Johnsen AT, Madsen LJ, et al. Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review. Public Health 2021;190:67–74. https://doi.org/10.1016/j.puhe.2020.10.025.
[17] Mosquera I, Mendizabal N, Martín U, et al. Inequalities in participation in colorectal cancer screening programmes: a systematic review. Eur J Public Health 2020;30:416–25. https://doi.org/10.1093/eurpub/ckz236.
[18] Unanue-Arza S, Solís-Ibinagagoitia M, Díaz-Seoane M, et al. Inequalities and risk factors related to non-participation in colorectal cancer screening programmes: a systematic review. Eur J Public Health 2021;31:346–55. https://doi.org/10.1093/eurpub/ckaa203.
[19] González LV, Sotos FE, de Miguel Ibáñez R. Colorectal Cancer Screening in Castilla La Mancha, Spain: The Influence of Social, Economic, Demographic and Geographic Factors. J Community Health 2022;47:446–53. https://doi.org/10.1007/s10900-022-01071-x.
[20] Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 2019;68:2179–85. https://doi.org/10.1136/gutjnl-2019-319511.
[21] Cayuela L, Flox-Benítez G, Peiró Villalba C, et al. Investigating temporal patterns of colorectal cancer incidence in Spain: a comprehensive analysis of age, period and cohort effects, 1990-2019. Revista Espanola de Enfermedades Digestivas 2024;116:312–8. https://doi.org/10.17235/reed.2024.10317/2024.
[22] Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–71. https://doi.org/10.1016/S0140-6736(96)03430-7.
[23] Qaseem A, Harrod CS, Crandall CJ, et al. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (Version 2). Ann Intern Med 2023;176:1092–100. https://doi.org/10.7326/M23-0779.
[24] Ladabaum U, Mannalithara A, Meester RGS, et al. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years. Gastroenterology 2019;157:137–48. https://doi.org/10.1053/j.gastro.2019.03.023.
[25] van de Schootbrugge-Vandermeer HJ, Toes-Zoutendijk E, de Jonge L, et al. When to Start, When to Stop With Colorectal Cancer Screening: A Cost-Effectiveness Analysis. Gastroenterology 2024;167:801-803.e5. https://doi.org/10.1053/j.gastro.2024.05.007.